The DEA has extended COVID-era flexibilities while permanent rules are being finalized. Monitor the Federal Register for comment periods — the final rule may significantly change how controlled substances are prescribed via telemedicine.
Full editorial content for this post is being prepared by our team.
Source · DEA · federalregister.gov
Sources
DEA · federalregister.gov
This post cites primary sources and was reviewed before publication. Not for legal or clinical decision-making. For compliance decisions with regulatory consequences, confirm requirements directly with your state board.